Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGAV | P06756 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | IAPP | P10997 | 2/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Orthocresol SCHEMBL4085176 | 0.89 | CES2 (0.47) | HDAC3HDAC1HDAC2HDAC8CES2 | |
| Catechol SCHEMBL28191561 | 0.88 | HDAC3 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| O-Xylene SCHEMBL10995385 | 0.88 | HDAC3 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Hexanoate SCHEMBL8539398 | 0.87 | AKR1B1 (0.55) | CES2CES1AKR1B1ALDH1A1KMT2A | |
| Orthocresol SCHEMBL11464146 | 0.86 | AKR1B1 (0.48) | FFAR3CES2CES1AKR1B1ALDH1A1 | |
| Orthocresol SCHEMBL28747710 | 0.81 | TRPA1 (0.50) | AKR1B1ALDH1A1SMN1; SMN2KMT2AHPGD | |
| Orthocresol SCHEMBL6566573 | 0.81 | TRPA1 (0.50) | AKR1B1ALDH1A1SMN1; SMN2KMT2AHPGD | |
| Orthocresol SCHEMBL27576819 | 0.81 | TRPA1 (0.50) | ALDH1A1SMN1; SMN2KMT2AHPGDL3MBTL1 | |
| Pyrogallol SCHEMBL19857036 | 0.80 | IAPP (0.56) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Orthocresol SCHEMBL2005162 | 0.80 | AKR1B1 (0.47) | HDAC1HDAC2AKR1B1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100415233-C | Oral preparation | WYETH CORP (US) | 2008-09-03 | — | — | CN | claimed |
| EP-1945667-A1 | COMPOSITION AND METHOD FOR THE TREATMENT OF VIRAL INFECTION USING CAMELID HEAVY CHAIN ANTIBODIES | Prendergast, Patrick T. (AU) | 2008-07-23 | — | — | EP | claimed |
| WO-2007052242-A1 | COMPOSITION AND METHOD FOR THE TREATMENT OF VIRAL INFECTION USING CAMELID HEAVY CHAIN ANTIBODIES | PRENDERGAST PATRICK T (AU) | 2007-05-10 | — | — | WO | claimed |
| CN-1764459-A | Oral formulations | WYETH CORP (US) | 2006-04-26 | — | — | CN | claimed |
| CN-1628773-A | Botanical originated nim oil sperm killing formulation | WU CHENGKUI (CN) | 2005-06-22 | — | — | CN | claimed |
| EP-0434437-A2 | Photohardenable or thermohardenable compositions and photosensitive materials utilising such photohardenable compositions | THE MEAD CORPORATION (US) | 1991-06-26 | — | — | EP | claimed |
| US-20230391942-A1 | AQUEOUS BIO-BASED ENERGY CURABLE POLYURETHANE COMPOSITION | ALLNEX BELGIUM S.A. (BE) | 2023-12-07 | — | — | US | disclosed |
| EP-4263650-A1 | AQUEOUS BIO-BASED ENERGY CURABLE POLYURETHANE COMPOSITION | Allnex Belgium, S.A. (BE) | 2023-10-25 | — | — | EP | disclosed |
| US-11560488-B2 | Ultraviolet curable ink composition, method for manufacturing bezel pattern in display substrate by using same, and bezel pattern manufactured thereby | LG CHEM, LTD. | 2023-01-24 | — | — | US | disclosed |
| EP-3357943-B1 | MODIFIED CONJUGATED DIENE-BASED POLYMER AND METHOD OF PREPARING THE SAME | LG CHEMICAL LTD (KR) | 2022-07-20 | — | — | EP | disclosed |
| WO-2022128462-A1 | AQUEOUS BIO-BASED ENERGY CURABLE POLYURETHANE COMPOSITION | ALLNEX BELGIUM, S.A. (BE) | 2022-06-23 | — | — | WO | disclosed |
| EP-4015548-A1 | AQUEOUS BIO-BASED ENERGY CURABLE POLYURETHANE COMPOSITION | Allnex Belgium, S.A. (BE) | 2022-06-22 | — | — | EP | disclosed |
| US-10906995-B2 | Modifier and modified and conjugated diene-based polymer prepared using the same | LG CHEM, LTD. | 2021-02-02 | — | — | US | disclosed |
| EP-0434437-A2 | Photohardenable or thermohardenable compositions and photosensitive materials utilising such photohardenable compositions | THE MEAD CORPORATION (US) | 1991-06-26 | — | — | EP | disclosed |
| EP-0356868-A2 | A method of treating a tooth with adhesive dental cavity basing composition | DENTSPLY INTERNATIONAL, INC. (US) | 1990-03-07 | — | — | EP | disclosed |
| US-4115406-A | 2-Alkyl-4-phenyl-dihydropyrans and processes for augmenting the organoleptic properties of foodstuffs and tobacco using one or more of said pyrans | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4071034-A | 2-Alkyl-4-phenyl-dihydropyrans and processes for augmenting the organoleptic properties of tobacco using one or more of said pyrans | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-01-31 | — | — | US | disclosed |
| US-4071535-A | 2-Alkyl-4-phenyl-dihydropyrans and processes for augmenting the organoleptic properties of foodstuffs and tobacco using one or more of said pyrans | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-01-31 | — | — | US | disclosed |
| US-4070491-A | 2-Alkyl-4-phenyl-dihydropyrans and processes for augmenting the organoleptic properties of foodstuffs and tobacco using one or more of said pyrans | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-01-24 | — | — | US | disclosed |
| US-4010286-A | Flavoring with 4-methyl-1-oxaspiro[5.5]undecane | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10906995-B2 | Modifier and modified and conjugated diene-based polymer prepared using the same | RIF1, FDFT1, CAD | FFAR3 2973/4885HDAC3 2120/4885HDAC1 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.